Polyclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1)
PICD; IDP; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; Cytosolic NADP-isocitrate dehydrogenase
- Product No.PAH839Mu01
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen RPH839Mu01-Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- TraitsLiquid
- Concentration0.5mg/ml
- Organism Species Moren/a
- ApplicationsWB; IHC
 If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
    
                                    US$ 108 
            
                
                        US$ 252 
                                        US$ 360 
                                        US$ 900 
                                        US$ 3600 
                            
 For more details, please contact local distributors!
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against IDH1. It has been selected for its ability to recognize IDH1 in immunohistochemical staining and western blotting.
USAGE
        Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                     Antibody Labeling Customized Service Antibody Labeling Customized Service
- 
                     Protein A/G Purification Column Protein A/G Purification Column
- 
                     Staining Solution for Cells and Tissue Staining Solution for Cells and Tissue
- 
                     Positive Control  for Antibody Positive Control  for Antibody
- 
                     Tissue/Sections Customized Service Tissue/Sections Customized Service
- 
                     Phosphorylated Antibody Customized Service Phosphorylated Antibody Customized Service
- 
                     Western Blot (WB) Experiment Service Western Blot (WB) Experiment Service
- 
                     Immunohistochemistry (IHC) Experiment Service Immunohistochemistry (IHC) Experiment Service
- 
                     Immunocytochemistry (ICC) Experiment Service Immunocytochemistry (ICC) Experiment Service
- 
                     Flow Cytometry (FCM) Experiment Service Flow Cytometry (FCM) Experiment Service
- 
                     Immunoprecipitation (IP) Experiment Service Immunoprecipitation (IP) Experiment Service
- 
                     Immunofluorescence (IF) Experiment Service Immunofluorescence (IF) Experiment Service
- 
                     Buffer Buffer
- 
                     DAB Chromogen Kit DAB Chromogen Kit
- 
                     SABC Kit SABC Kit
- 
                     Long-arm Biotin Labeling Kit Long-arm Biotin Labeling Kit
- 
                     Real Time PCR Experimental Service Real Time PCR Experimental Service
| Magazine | Citations | 
| Molecular & Cellular Proteomics | Identification of IDH1 as a Potential Diagnostic and Prognostic Biomarker for Non-small-cell Lung Cancer by Proteomic Analysis Mcponline: 008821 | 
| Molecular & Cellular Proteomics | Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis Pubmed: 22064513 | 
| Clinical Cancer Research | Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer Pubmed: 24046070 | 
| Onco Targets Ther | The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells PubMed: 25914546 | 
| Oncogene | Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism Pubmed:29921847 | 
| Molecular Oncology | IDH 2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer Pubmed:29465809 | 
| Cancers | Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver … Pubmed: 32443439 | 
| International Journal of Cancer | Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer Pubmed:35689436 | 
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) | 
| RPH839Mu01 | Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAH839Mu01 | Polyclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1) | WB; IHC | 
| LAH839Mu81 | FITC-Linked Polyclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1) | WB; IHC; ICC; IF. | 
| LAH839Mu71 | Biotin-Linked Polyclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1) | WB | 
 
         
 
                             
                             
                             
                            

 
    